Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling. - Wikidata - awgldk - TriplyDB

Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.

Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.

http://www.wikidata.org/entity/Q35083176

about

Insights into the key roles of proteoglycans in breast cancer biology and translational medicine Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer The HIV matrix protein p17 promotes the activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2.p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion.Emerging therapeutic targets in metastatic progression: A focus on breast cancer.Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway.Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer.Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study MicroRNA regulation of proteoglycan function in cancer.Wnt Signaling Cascades and the Roles of Syndecan Proteoglycans.Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway.MDA-MB-231 breast cancer cell viability, motility and matrix adhesion are regulated by a complex interplay of heparan sulfate, chondroitin-/dermatan sulfate and hyaluronan biosynthesis.Anti-human CD138 monoclonal antibodies and their bispecific formats: generation and characterization.Positive lymph-node breast cancer patients – activation of NF-κB in tumor-associated leukocytes stimulates cytokine secretion that promotes metastasis via C-C chemokine receptor CCR7.Wnt signaling in triple-negative breast cancer.HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression.Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.Dually modified transmembrane proteoglycans in development and disease.Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1.Nicotine-enhanced stemness and epithelial-mesenchymal transition of human umbilical cord mesenchymal stem cells promote tumor formation and growth in nude mice.Cytokines, breast cancer stem cells (BCSCs) and chemoresistance ZNRF1 can inhibit proliferation and stemness properties of leukemia NB4 cells Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways

P2860

Q28085548-87DA0EEA-62CE-42F4-BE56-8BC0DAF943C4 Q30660919-EF917532-5E0F-4941-A7A0-A0B9CADA585D Q34442828-19B63B58-40DE-4DBD-A588-45EB4317433B Q34499650-678B730B-889F-4FA8-BAFD-514C3E44C8FF Q35149334-9CAF5282-B0B7-4F2B-8D63-A2D9DDF43CEB Q36687990-6661A756-775B-45A0-B058-3AFF8FC908CB Q36854062-8F873E56-9B3F-4B0F-96BA-23B09DB2ED5B Q37108420-9595D133-D5DE-4534-BA05-906872F348F5 Q37619770-611FFCB0-4D9F-417A-B0B9-1AFE7CCD860D Q37686006-7D5544B2-730B-4FBA-B938-869E4BF953EF Q37697134-5B9BF3B3-B6E9-428E-B625-EC22AA03A161 Q37747899-B163DCC6-C1C7-4430-96A5-95C8E3B7992B Q38244283-4E60C62B-528C-414D-B7C2-8BC49A0058CF Q38441061-C8276D84-4ECF-404E-B4D1-8377BF2495F6 Q38736999-3370980E-E31B-4DB6-8023-74BE8FBD3714 Q38741058-4E7BBFA2-DF47-4D00-8485-E595736D3B08 Q38787948-C8AF8C73-D5CB-40CA-B171-6CDD6F81FF0A Q39110988-E58E9091-FF33-4449-ADDA-3BB2C46B119C Q39214992-AE935FE6-03D8-440E-92FA-9CE9E6FD28D6 Q42457789-DC871E01-8ED0-497D-830C-6391E5C16193 Q46450905-DDA10B4F-C7BA-42C5-AB0D-4AF0E6B925EC Q47240245-293371AB-D2FE-451D-9A49-628912C4FDC9 Q47318797-80DF0045-1569-422F-B3CA-C207FB25899E Q49530301-EF88E7E0-7832-40B6-B91F-FDFD316E7457 Q57106445-C5DFD99D-F6B2-41D0-A839-7BC18C82F8B3 Q58156125-7B2D5912-6FBA-4B3E-A652-F10C90A612A1 Q58695612-6A741C18-317D-4949-A0CB-87DA5329033E

P2860

Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.

http://www.wikidata.org/entity/Q35083176

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Syndecan-1 (CD138) modulates t ...... IL-6-mediated STAT3 signaling.

@ast

Syndecan-1 (CD138) modulates t ...... IL-6-mediated STAT3 signaling.

@en

type

label

Syndecan-1 (CD138) modulates t ...... IL-6-mediated STAT3 signaling.

@ast

Syndecan-1 (CD138) modulates t ...... IL-6-mediated STAT3 signaling.

@en

prefLabel

Syndecan-1 (CD138) modulates t ...... IL-6-mediated STAT3 signaling.

@ast

Syndecan-1 (CD138) modulates t ...... IL-6-mediated STAT3 signaling.

@en

P1433

Q35083176-D20231A5-4C37-4B43-8682-46BF236F8BD0

P1476

Q35083176-180051D9-79E2-43D0-A965-C63479C32E75

P2093

Q35083176-30A650FF-8C1F-4AE4-B847-AC1EA67321DE

Q35083176-33C00AD2-C1B1-4998-ABF3-6AD0551C5AFD

Q35083176-45E5E91C-0DA5-41CF-A9CC-092D766ECA66

Q35083176-4B9D423C-0825-4DE9-B33D-8F2D341C5858

Q35083176-4DBE6660-3F6D-4858-ACEE-63221B0A55AC

Q35083176-54EC8422-5C0C-45CC-AE7E-983474C7D25E

Q35083176-5BF71BB7-746B-4795-B4CC-79D4D35ACE35

Q35083176-636C29E0-65CA-4130-85CF-3C1D4540F345

Q35083176-BB2DE684-39A7-4129-97AF-39258E0D9389

Q35083176-F7669EC3-2D7A-4B76-A2E7-E86676D3DA6C

P2860

Q35083176-045F0F49-D851-4B82-8126-F778E4A8DDE1

Q35083176-084AE3AF-85B4-4CC8-8DEA-88432DB95223

Q35083176-114AAE4D-CBCC-476E-84C4-1074F7A6A226

Q35083176-1864C195-5DA5-4552-B93F-991FE7B63B10

Q35083176-1A17085A-A9DA-4AFA-8468-B9288E1B7D08

Q35083176-241C128F-F466-433B-8567-EF603F5EAC67

Q35083176-34F54DA7-D54D-4D12-82C1-CC55370D1D66

Q35083176-35A8D363-3046-4A44-A16F-FE8EA00871AA

Q35083176-38AA15A8-6DA6-4503-ADA8-56975CC34400

Q35083176-3B5BD037-05D9-451B-9252-8DC937972BCB

P304

Q35083176-0710B7A5-EBE6-4F75-96DC-7F4B67D30893

P31

Q35083176-A594F25E-32EB-4AEF-BC8D-2C6CC2BF8C05

P356

Q35083176-AFBB7E11-66B8-4A4C-A3A8-16186A5AAEF9

P407

Q35083176-D0187A51-3ED4-4A68-ACC3-408FC973EFB6

P433

Q35083176-B1869998-4916-4FA0-AC35-A48E1C312917

P478

Q35083176-5C75A7AB-07F3-4A01-9BC6-D49526F8F9FE

P50

Q35083176-226E6A9C-A39F-4956-B51D-D004F45FB651

Q35083176-BF38167C-BBE8-4DFF-8CBC-65F48CA3B26B

Q35083176-CA4AB3A6-F8B3-4760-B24C-C372DBB0D145

P577

Q35083176-E4FAC6A5-AB9E-41B3-9187-F78E889F132A

P5875

Q35083176-09B1EE82-B652-4D14-B0FB-E9C443FB9B24

P698

Q35083176-9A44356A-1C17-4A6E-AD89-EE7E1D144421

P932

Q35083176-4AFBA970-E34C-4786-A026-E102642CD8CD

P356

JOURNAL.PONE.0085737

P1433

P1476

Syndecan-1 (CD138) modulates t ...... IL-6-mediated STAT3 signaling.

@en

P2093

Archana Vijaya Kumar

http://www.w3.org/2001/XMLSchema#string

Burkhard Greve

http://www.w3.org/2001/XMLSchema#string

Cornelia Schneider

http://www.w3.org/2001/XMLSchema#string

Hans Theodor Eich

http://www.w3.org/2001/XMLSchema#string

Ileana Zucchi

http://www.w3.org/2001/XMLSchema#string

Laura Vilardo

http://www.w3.org/2001/XMLSchema#string

Ludwig Kiesel

http://www.w3.org/2001/XMLSchema#string

Reinhard Kelsch

http://www.w3.org/2001/XMLSchema#string

Rolland Reinbold

http://www.w3.org/2001/XMLSchema#string

Sampath Katakam Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ

Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes

Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells

Inflammation and cancer

The epithelial-mesenchymal transition generates cells with properties of stem cells

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

Exploring the role of cancer stem cells in radioresistance

Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies

P304

e85737

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0085737

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Hebatallah Hassan

Sherif A Ibrahim

P577

2013-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259589412

http://www.w3.org/2001/XMLSchema#string

P698

24392029

http://www.w3.org/2001/XMLSchema#string

P932

3877388

http://www.w3.org/2001/XMLSchema#string